European Medicines Agency building sign exterior

REGULATORY

10 Dec 2025

Europe Draws Clear Lines for Synthetic Peptides

The EMA issues its first dedicated guideline for synthetic peptide drugs, clarifying quality and manufacturing rules from June 2026

Rubicon office building exterior

INVESTMENT

18 Nov 2025

Europe Doubles Down on Peptide Power

Rubicon backs Sweden’s PeptiSystems as Europe accelerates investment in peptide manufacturing to meet rising global demand

Continuous-flow peptide synthesis equipment in lab

INNOVATION

13 Nov 2025

Flow Manufacturing Signals Europe’s Peptide Future

As peptide drug demand surges, European manufacturers look to continuous-flow technology to cut waste, boost scale, and stay competitive

Pharmaceutical peptide manufacturing equipment in cleanroom

INNOVATION

2 Nov 2025

Microbes and Muscle: Europe’s Peptide Bet

Ajinomoto Bio-Pharma and Olon team up to expand peptide manufacturing in Europe and strengthen supply resilience

PolyPeptide facility building exterior

PARTNERSHIPS

29 Oct 2025

Peptide Partnerships Redefine Drug Production

PolyPeptide and Lifecore join forces to streamline US peptide manufacturing from API to finished injectable therapies

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.